Når MabThera anvendes til behandling af ikke- Hodgkins lymfom, er de hyppigste bivirkninger (som optræder hos flere end 1 ud af 10 patienter) bakterieinfektioner, virusinfektioner, bronkitis (betændelse i luftvejene i lungerne), neutropeni (lavt antal hvide blodlegemer (neutrofiler)), leukopeni (lavt antal leukocytter, en anden type hvide blodlegemer), febril neutropeni (neutropeni med feber), reaktioner i forbindelse med infusionen (hovedsagelig feber, kulderystelser og rysten), angioødem (hævelser under huden), kvalme, pruritus (kløe), udslæt, hårtab, feber, kulderystelser, asteni (kraftesløshed), hovedpine og faldende IgG- niveauer (en type antistof).
When used to treat non-Hodgkin’ s lymphoma, the most common side effects with MabThera (seen in more than 1 patient in 10) are bacterial infections, viral infections, bronchitis (inflammation of the airways in the lungs), neutropenia (low levels of neutrophils, a type of white blood cell), leucopenia (low levels of leucocytes, another type of white blood cell), febrile neutropenia (neutropenia with fever), reactions related to the infusion (mainly fever, chills and shivering), angioedema (swelling beneath the skin), nausea (feeling sick), pruritus (itching), rash, alopecia (hair loss), fever, chills, asthenia (weakness), headache and decreased levels of IgG (a type of antibody).